These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1723098)

  • 1. Inhibitory effect of levocabastine on experimental allergic conjunctivitis in guinea pigs.
    Kamei C; Izushi K; Tasaka K
    J Pharmacobiodyn; 1991 Aug; 14(8):467-73. PubMed ID: 1723098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological and clinical properties of levocabastine hydrochloride (eye drop and nasal spray), a selective H1 antagonist].
    Akiyoshi M; Shigeoka T; Torii S; Maki E; Enomoto S; Takahashi H; Hirano F
    Nihon Yakurigaku Zasshi; 2002 Mar; 119(3):175-84. PubMed ID: 11915520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levocabastine versus cromolyn sodium in the treatment of pollen-induced conjunctivitis.
    Ciprandi G; Cerqueti PM; Sacca S; Cilli P; Canonica GW
    Ann Allergy; 1990 Aug; 65(2):156-8. PubMed ID: 1974402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of certain antiallergic drugs on experimental conjunctivitis in guinea pigs.
    Kamei C; Izushi K; Nakamura S
    Biol Pharm Bull; 1995 Nov; 18(11):1518-21. PubMed ID: 8593470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of histamine-induced conjunctivitis to the assessment of a topical antihistamine, levocabastine.
    Feinberg G; Stokes TC
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):537-8. PubMed ID: 2883131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of tranilast ophthalmic solution on allergic conjunctivitis in guinea pigs].
    Itoh F; Komatsu Y; Taya F; Isaji M; Kojima M; Momose Y; Suzawa H; Miyata H; Shibazaki T
    Nihon Yakurigaku Zasshi; 1993 Jan; 101(1):27-32. PubMed ID: 7680329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New trends in the treatment of allergic conjunctivitis.
    Parys W; Blockhuys S; Janssens M
    Doc Ophthalmol; 1992; 82(4):353-60. PubMed ID: 1363981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats.
    Minami K; Hossen MA; Kamei C
    Biol Pharm Bull; 2005 Mar; 28(3):473-6. PubMed ID: 15744071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ketotifen fumarate, olopatadine, and levocabastine on ocular active anaphylaxis in the guinea pig and ocular immediate hypersensitivity in the albino rat.
    Schoch C
    Ocul Immunol Inflamm; 2005 Feb; 13(1):39-44. PubMed ID: 15804768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model.
    Abelson MB; George MA; Smith LM
    Ophthalmology; 1995 Feb; 102(2):310-6. PubMed ID: 7862419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.
    Dechant KL; Goa KL
    Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levocabastine eye drops versus sodium cromoglycate in seasonal allergic conjunctivitis.
    Wihl JA; Rudblad S; Kjellén H; Blychert LA
    Clin Exp Allergy; 1991 May; 21 Suppl 2():37-8. PubMed ID: 1680537
    [No Abstract]   [Full Text] [Related]  

  • 14. Levocabastine: pharmacological profile of a highly effective inhibitor of allergic reactions.
    Awouters F; Niemegeers CJ; Jansen T; Megens AA; Janssen PA
    Agents Actions; 1992 Jan; 35(1-2):12-8. PubMed ID: 1354927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S; McTavish D
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis.
    Azevedo M; Castel-Branco MG; Oliveira JF; Ramos E; Delgado L; Almeida J
    Clin Exp Allergy; 1991 Nov; 21(6):689-94. PubMed ID: 1685691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment for allergic conjunctivitis - Plant derived histidine decarboxylase inhibitor and H1 antihistaminic drug.
    Bakrania AK; Patel SS
    Exp Eye Res; 2015 Aug; 137():32-8. PubMed ID: 26028180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis.
    Frostad AB; Olsen AK
    Clin Exp Allergy; 1993 May; 23(5):406-9. PubMed ID: 8101467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid onset of action of levocabastine eye-drops in histamine-induced conjunctivitis.
    Stokes TC; Feinberg G
    Clin Exp Allergy; 1993 Sep; 23(9):791-4. PubMed ID: 10779311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
    Yanni JM; Stephens DJ; Miller ST; Weimer LK; Graff G; Parnell D; Lang LS; Spellman JM; Brady MT; Gamache DA
    J Ocul Pharmacol Ther; 1996; 12(4):389-400. PubMed ID: 8951675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.